Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Claritas Pharmaceuticals Inc (CLAZF)
:CLAZF
Holding CLAZF?
Track your performance easily
CLAZF Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume4.20K
Average Volume (3M)169.00
Market Cap
$782.52K
Enterprise ValueN/A
Total Cash (Recent Filing)$673.00K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta3147.71
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding37,786,587
10 Day Avg. Volume0
30 Day Avg. Volume169
Standard Deviation32.11
R-Squared0.00595
Alpha11.80
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
CLAZF FAQ
What was Claritas Pharmaceuticals Inc’s price range in the past 12 months?
Currently, no data Available
What is Claritas Pharmaceuticals Inc’s market cap?
Claritas Pharmaceuticals Inc’s market cap is $782.52K.
When is Claritas Pharmaceuticals Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Claritas Pharmaceuticals Inc’s earnings last quarter?
Currently, no data Available
Is Claritas Pharmaceuticals Inc overvalued?
According to Wall Street analysts Claritas Pharmaceuticals Inc’s price is currently Overvalued.
Does Claritas Pharmaceuticals Inc pay dividends?
Claritas Pharmaceuticals Inc does not currently pay dividends.
What is Claritas Pharmaceuticals Inc’s EPS estimate?
Claritas Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Claritas Pharmaceuticals Inc have?
Claritas Pharmaceuticals Inc has 37,786,587 shares outstanding.
What happened to Claritas Pharmaceuticals Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Claritas Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in CLAZF
---
Company Description
Claritas Pharmaceuticals Inc
Kalytera Therapeutics, Inc. engages in the development of next generation cannabinoid therapeutics. It also offers development programs for bon fracture healing; osteogenesis imperfecta; osteoporosis; and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan on October 15, 2004 and is headquartered in Novato, CA.
---
Artelo Biosciences
―
China Pharma Holdings
―
CytoDyn
―
Enzolytics
―
EyePoint Pharmaceuticals
―
Xencor
―
---